Zeronda Tyler
SEC insider (Form 3/4/5 filer). CIK 0001867033. CHIEF FINANCIAL OFFICER at VYNE Therapeutics Inc. (VYNE). 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 27, 2026. Located in STEWARTSVILLE, NJ.
Companies Zeronda Tyler has filed insider reports for
- VYNE Therapeutics Inc. (VYNE): Officer, CHIEF FINANCIAL OFFICER
Zeronda Tyler
CIK: 0001867033
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VYNE Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 27, 2026YARW
Yarrow Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
185.8K shares- - Jul 23, 2026VYNE
VYNE Therapeutics Inc.
Tax PaymentDirect22.5K shares at avg. $0.90$20K - Jun 30, 2026VYNE
VYNE Therapeutics Inc.
Tax PaymentDirect3.5K shares at avg. $0.65$2K - Mar 31, 2026VYNE
VYNE Therapeutics Inc.
Tax PaymentDirect4K shares at avg. $0.60$2K - Dec 31, 2025VYNE
VYNE Therapeutics Inc.
Tax PaymentDirect7.9K shares at avg. $0.58$5K - Sep 30, 2025VYNE
VYNE Therapeutics Inc.
Tax PaymentDirect3.4K shares at avg. $0.34$1K - Jun 30, 2025VYNE
VYNE Therapeutics Inc.
Tax PaymentDirect3.4K shares at avg. $1.65$6K - Mar 31, 2025VYNE
VYNE Therapeutics Inc.
Tax PaymentDirect8.4K shares at avg. $1.58$13K - Jan 21, 2025VYNE
VYNE Therapeutics Inc.
AwardDirectStock Option (right to buy)
230K shares- - Dec 31, 2024VYNE
VYNE Therapeutics Inc.
Tax PaymentDirect4.7K shares at avg. $3.35$16K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 27, 2026 |  YARW Yarrow Bioscience, Inc. | Award Stock Option (Right to Buy) | 185,798 | - | - | Direct |
| Jul 23, 2026 | VYNE VYNE Therapeutics Inc. | Tax Payment | 22,516 | $0.90 | $20,210 | Direct |
| Jun 30, 2026 | VYNE VYNE Therapeutics Inc. | Tax Payment | 3,464 | $0.65 | $2,254 | Direct |
| Mar 31, 2026 | VYNE VYNE Therapeutics Inc. | Tax Payment | 4,007 | $0.60 | $2,394 | Direct |
| Dec 31, 2025 | VYNE VYNE Therapeutics Inc. | Tax Payment | 7,858 | $0.58 | $4,558 | Direct |
| Sep 30, 2025 | VYNE VYNE Therapeutics Inc. | Tax Payment | 3,420 | $0.34 | $1,146 | Direct |
| Jun 30, 2025 | VYNE VYNE Therapeutics Inc. | Tax Payment | 3,420 | $1.65 | $5,643 | Direct |
| Mar 31, 2025 | VYNE VYNE Therapeutics Inc. | Tax Payment | 8,399 | $1.58 | $13,270 | Direct |
| Jan 21, 2025 | VYNE VYNE Therapeutics Inc. | Award Stock Option (right to buy) | 230,000 | - | - | Direct |
| Dec 31, 2024 | VYNE VYNE Therapeutics Inc. | Tax Payment | 4,675 | $3.35 | $15,661 | Direct |
1-10 of 11 transactions